from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1547/dnaE1

LFCtreatmentdescriptionclass of inhibitor

-0.527

Amikacinug/mL Amikacintranslation

-1.140

Cap5-10ug/mL Capreomycintranslation

-0.784

Rox10-50 ug/mL Roxithromycintranslation

-0.406

SM2-5 ug/mL Streptomycintranslation

-2.441

Tet5-10 ug/mL Tetracyclinetranslation

0.878

Rif0.2-5ug/mL Rifampicintranscription

0.421

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.664

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.487

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.199

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.396

Clofazimine10-13 ug/mL Clofaziminerespiration

0.299

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.889

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.608

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.796

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.270

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.014

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.878

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.984

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.360

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.017

KCN5-20 ug/mL Potassium cyaniderespiration

-0.730

NaN30.2-2 mM Sodium aziderespiration

0.010

Nigericin50 uM Nigericinrespiration

-0.843

TRC10-150 ug/mL Triclosanrespiration

-1.100

TRZ10-25 ug/mL Thioridazinerespiration

-3.015

Valinomycin0.5-10 uM Valinomycinrespiration

0.574

ZnSO42 mM ZnSO4respiration

-0.898

menadione6-10 ug/mL Menadionerespiration

0.057

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.541

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.344

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.627

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.710

NRP_1Non-replicating persistence stage 1dosRassociated

0.784

Amp0.2mg/mL AmpicillincellWall

0.856

Cephalexin20-100 ug/mL CephalexincellWall

0.052

Cerulenin0.32-5 ug/mL CerulenincellWall

1.082

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.590

EMB10-20 ug/mL EthambutolcellWall

0.495

Eta12-40 ug/mL EthionamidecellWall

0.796

INH0.2-0.4 ug/mL IsoniazidcellWall

0.452

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.512

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.472

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.329

BZA0.12 mg/mL BenzamidearomaticAmides

0.180

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.127

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.589

H2O24 mM hydrogen peroxideDNAdamaging

1.073

Levo10 ug/mL LevofloxacinDNAdamaging

0.736

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.991

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.456

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.044

UVUV-irradiationDNAdamaging

-0.907

ARP41-4 ug/mL Antitubercular compound ARP4?

0.193

Antimycin12.5-50 ug/mL Antimycin A?

0.372

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.350

PA_110-50 ug/mL Antitubercular compound PA-1?

0.457

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.753

PA8240.2-2 ug/mL PA-824?

-0.407

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.128

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.089

Verapamil50 uM Verapamil?

-0.081

mercaptoethanol2 mM 2-Mercaptoethanol?

0.480

methoxatin10-20 ug/mL Methoxatin?